Loading...
About this episode
Artificial intelligence is playing an increasingly important role in the way new drugs are discovered. It’s radically changing how this process works, and speeding up the development of new therapies.
We Meet:
Alex Zhavoronkov, CEO at Insilico Medicine
Mike Nally, CEO at Generate Biomedicines
Credits:
This episode of SHIFT was produced by Jennifer Strong with help from Emma Cillekens. It was mixed by Garret Lang, with original music from him and Jacob Gorski. Art by Meg Marco.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
